clock menu more-arrow no yes

Filed under:

Manchester United consider Alex Ferguson gesture of support

New, comments

For the absolute boy

If you buy something from an SB Nation link, Vox Media may earn a commission. See our ethics statement.

Manchester United v Arsenal - Premier League
Alex Ferguson and two fans.
Photo by Clive Brunskill/Getty Images

As it seems that Alex Ferguson is recovering from his brain surgery, Manchester United are ready to give him a gesture of support in their last home game of the season. Before the FA Cup final, they play Watford in the Premier League, and while they will doubtless draw 0-0, they will also do something constructive with the day. It’s a lovely thing that he is getting better, and we can all hope that this is gets a lot better, a lot quickly.

There’s a bit of a mistake with central midfielders. People assume they’re tactically aware and that they will make good managers. Someone who disproves that is Michael Carrick, who is an occasionally brilliant midfielder. He can be an important one, too, but more than anything he was a midfielder who could not improve from the age of 25 onwards. He wants to become a manager one day, which means that he needs to finally learn how midfielders should track runners, and how they should offer more assistance in attack. A good player, far from a great one.

The Mirror have deliberately read things the wrong way with Jose Mourinho’s press conference, where he was fairly bullish about him staying, but left it open about Paul Pogba and his agent still to request a move. It seems like we can expect him to stay another season, but let’s see what happens, because the world is largely given over to money.

Mourinho has also correctly identified that there are some United players who will never make the grade at the top. Off the top of my head: Romero, Darmian, Shaw, Blind, Smalling, Jones, McTominay, Lingard, Martial, and others make the list. There are more, but then there always are.

And lastly, one of the hottest stocks in biotech, Fibrogen, are worth a look after their latest earnings call.